A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]

Klapproth AP, Shevtsov M, Stangl S, Li WB, MulthoffG. Int J Nanomedicine. 2020;15:4677-4689.The authors have advised the author and affiliation list onpage 4677 is incorrect. The correct author list and affiliationsare as follows. Alexander P Klapproth1,2,*Maxim Shevtsov1,3-7,*Thomas J Carter8Stefan Stangl1Kerry Chester8Wei Bo Li2Gabriele Multhoff1 1Center for Translational Cancer Research Technische Universität München(TranslaTUM), Klinikum Rechts Der Isar, Munich, Germany; 2Institute ofRadiation Medicine, Helmholtz Zentrum München, German ResearchCenter for Environmental Health (GmbH), Munich, Germany; 3Institute ofCytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia;4Department of Biotechnology, First Pavlov State Medical University ofSt. Petersburg, St. Petersburg, Russia; 5Almazov National Medical ResearchCentre, Russian Polenov Neurosurgical Institute, St. Petersburg, Russia;6National Center for Neurosurgery, Nur-Sultan, Kazakhstan; 7Departmentof Biomedical Cell Technologies, Far Eastern Federal University, Vladivostok,Russia; 8UCL Cancer Institute, University College London, London, UK *These authors contributed equally to this work Page 4682, Intravenously Injected SPIONs section, thetext "To further validate the model, two datasets frommice with intravenously injected SPIONs were analyzed"should read "To further validate the model, two previouslypublished supplementary datasets from mice with intravenouslyinjected SPIONs were analyzed". Read the original article